BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28054399)

  • 1. Comparison of effects of zoledronic acid and clodronate on the bone structure: imaginological and histomorphometrical study in vivo.
    Martelli SJR; Damian MF; Gomes APN; Schinestsck AR; Silva AER; Vasconcelos ACU
    J Oral Pathol Med; 2017 Sep; 46(8):632-636. PubMed ID: 28054399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging and histomorphometric evaluation of mandible and tibia of rats treated with bisphosphonates.
    Martelli SJR; Damian MF; Schinestsck AR; Schuch LF; Cascaes AM; Vasconcelos ACU
    Oral Maxillofac Surg; 2019 Dec; 23(4):473-479. PubMed ID: 31686251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation.
    Vasconcelos AC; Berti-Couto SA; Azambuja AA; Salum FG; Figueiredo MA; da Silva VD; Cherubini K
    J Oral Pathol Med; 2012 Oct; 41(9):702-12. PubMed ID: 22417074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: histological and histomorphometrical evaluation in rats.
    de Oliveira MA; Asahi DA; Silveira CAE; Lima LAPA; Glick M; Gallottini M
    Clin Oral Implants Res; 2015 Apr; 26(4):e17-e21. PubMed ID: 24438459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
    Daubiné F; Le Gall C; Gasser J; Green J; Clézardin P
    J Natl Cancer Inst; 2007 Feb; 99(4):322-30. PubMed ID: 17312309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
    Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
    Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental model of osteonecrosis of the jaw in rats treated with zoledronic acid.
    Kolpakova ME; Zubarevа AA; Artamonova TD; Lisovskaya EK; Chefu SG; Yagmurov OD; Yaremenko AI; Vlasov TD
    Br J Oral Maxillofac Surg; 2017 Feb; 55(2):156-159. PubMed ID: 27780611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of vascular endothelial growth factor (VEGF) in interradicular bone marrow in olpadronate treated animals.
    Bigi MM; Escudero ND; Ubios AM; Mandalunis PM
    Acta Odontol Latinoam; 2010; 23(3):265-9. PubMed ID: 21638970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
    Fournier P; Boissier S; Filleur S; Guglielmi J; Cabon F; Colombel M; Clézardin P
    Cancer Res; 2002 Nov; 62(22):6538-44. PubMed ID: 12438248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
    Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
    Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cortical bone channels network and osteocyte organization after the use of zoledronic acid.
    Rabelo GD; Travençolo BA; Oliveira MA; Beletti ME; Gallottini M; Silveira FR
    Arch Endocrinol Metab; 2015 Dec; 59(6):507-14. PubMed ID: 26331228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis.
    Koparal M; Gülsün B; Deveci E; Agacayak KS; Hamidi A
    Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):117-25. PubMed ID: 27386633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Zoledronic Acid in Experimental Periapical Lesions in Rats: An Imaging and Histological Analysis.
    França TRT; Ramos-Perez FMM; Pontual ADA; Castro JFL; Bonan PRF; Perez DEDC
    Braz Dent J; 2017; 28(5):566-572. PubMed ID: 29215680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates as anticancer therapy for early breast cancer.
    Mahtani R; Jahanzeb M
    Clin Breast Cancer; 2010 Oct; 10(5):359-66. PubMed ID: 20920980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
    Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
    J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen-containing bisphosphonate therapy: assessment of the alveolar bone structure in rats - a blind randomized controlled trial.
    Pacheco VN; Langie R; Etges A; Ponzoni D; Puricelli E
    Int J Exp Pathol; 2015 Aug; 96(4):255-60. PubMed ID: 26119047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study.
    Juillard A; Falgayrac G; Cortet B; Vieillard MH; Azaroual N; Hornez JC; Penel G
    Bone; 2010 Nov; 47(5):895-904. PubMed ID: 20656084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats.
    Silveira FM; Etges A; Correa MB; Vasconcelos AC
    J Oral Maxillofac Res; 2016; 7(4):e3. PubMed ID: 28154747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.